MTOR and Parkinson disease: Specifically, mTOR signaling has been shown to be important for therapeutic responses in PD, adaptations to drugs of abuse, and DA system changes induced by ASD-linked mutations (Dadalko et al., 2015b; Kim et al., 2012; Kosillo and Bateup, 2021; Kosillo et al., 2019; Liu et al., 2018b; Malagelada et al., 2010; Mazei-Robison et al., 2011; Neasta et al., 2014; Zhu et al., 2019).